1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Talazoparib with enzalutamide for untreated hormone-sensitive metastatic prostate cancer with a homologous recombination repair mutation ID 6460

Awaiting development [GID-TA11534] Expected publication date: TBC

  • Project information
  • Project documents

31420-Talazoparib-Enzalutamide-for-Prostate-Cancer-V1.0-FEB2024-NON-CONF.pdf (nihr.ac.uk)